A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
about
Transgenic rodent Plasmodium berghei parasites as tools for assessment of functional immunogenicity and optimization of human malaria vaccinesPlasmodium cellular effector mechanisms and the hepatic microenvironmentChelation of Ca²⁺ ions by a peptide from the repeat region of the Plasmodium falciparum circumsporozoite protein.An unstable Th epitope of P. falciparum fosters central memory T cells and anti-CS antibody responses.Proposing low-similarity peptide vaccines against Mycobacterium tuberculosisVaccination with M2e-based multiple antigenic peptides: characterization of the B cell response and protection efficacy in inbred and outbred mice.Replacing adenoviral vector HVR1 with a malaria B cell epitope improves immunogenicity and circumvents preexisting immunity to adenovirus in mice.Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputsPreclinical vaccine study of Plasmodium vivax circumsporozoite protein derived-synthetic polypeptides formulated in montanide ISA 720 and montanide ISA 51 adjuvants.Plasmodium falciparum variability and immune evasion proceed from antigenicity of consensus sequences from DBL6ε; generalization to all DBL from VAR2CSA.Malaria Vaccine Development: Are Bacterial Flagellin Fusion Proteins the Bridge between Mouse and Humans?Identification and validation of a linear protective neutralizing epitope in the β-pore domain of alpha toxin.Epitope-focused peptide immunogens in human use adjuvants protect rabbits from experimental inhalation anthrax.T1BT* structural study of an anti-plasmodial peptide through NMR and molecular dynamicsVaccines against malaria - an update.The C-terminal region of Trypanosoma cruzi MASPs is antigenic and secreted via exovesicles.Development of a chimeric Plasmodium berghei strain expressing the repeat region of the P. vivax circumsporozoite protein for in vivo evaluation of vaccine efficacy.Enhanced immunogenicity of Plasmodium falciparum peptide vaccines using a topical adjuvant containing a potent synthetic Toll-like receptor 7 agonist, imiquimodImaging murine NALT following intranasal immunization with flagellin-modified circumsporozoite protein malaria vaccines.A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice.Dendrimer-based nanocarriers: a versatile platform for drug delivery.Pentapeptide commonality between Corynebacterium diphtheriae toxin and the Homo sapiens proteome.
P2860
Q21032495-8AB87971-BDA8-4364-8232-6C92B8F013A1Q28081143-37152B75-7013-4C14-8677-C78265CA4984Q33756504-9530CD7C-9A8E-4F3F-A768-A6009112AF84Q33830488-B8FEA432-5B47-4341-A687-053587BDD34EQ33961091-64CADB1C-B1F9-4976-ABA2-0E45814AC0CDQ34105207-9A5FF1EF-DF78-4DD8-8497-9FA698097A65Q34162092-F572A610-C855-443D-82B6-75B8F5B4F83EQ34490296-37F320C2-7466-4B00-BE10-E31C6670073FQ34546208-4077383C-55F3-4439-8B96-2F7B6139021FQ34571421-E2BD809E-9B11-41A8-A0EC-4CF64B5B1382Q34983659-9B664376-8A77-4B48-A99B-BC1E88609392Q35031839-447796E8-D729-4567-876D-B942E2560793Q35341887-AF38A26A-C693-4259-9721-187312CB4AEBQ36752043-8D381C7B-54D5-40CF-9FF7-F0FFA9C21B8FQ36933780-45D7C232-5B94-43B6-93A2-8F6A7211622AQ36980178-BA63D995-CE24-48D1-B666-A137721AA366Q37036065-01DE6FF2-D47D-42F9-9F91-A0339FECECFFQ37075435-C6A55C91-F02B-45C4-8924-C55DCDB05F7AQ37446364-D8351D6D-DDF2-474C-8342-E9C4AF7B6A17Q37844654-A688A67D-D200-4415-903F-D68D8A75A3D3Q38820422-6C14CE87-ACA7-4793-87C8-2611E47020A4Q46696206-5E348F53-8444-4494-BE52-07AD541349D8
P2860
A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
A linear peptide containing mi ...... ansgenic sporozoite challenge.
@en
type
label
A linear peptide containing mi ...... ansgenic sporozoite challenge.
@en
prefLabel
A linear peptide containing mi ...... ansgenic sporozoite challenge.
@en
P2093
P2860
P356
P1476
A linear peptide containing mi ...... ansgenic sporozoite challenge.
@en
P2093
Carlos Parra-Lopez
Carol Othoro Watta
Elizabeth H Nardin
Giane A Oliveira
J Mauricio Calvo-Calle
Jonathan Soverow
P2860
P304
P356
10.1128/IAI.01151-06
P407
P577
2006-10-09T00:00:00Z